Previous work in pancreatic cancer has showed that deletion of Lfng in a KrasLSL‐G12D mouse model upregulates Notch3 and Hes1, accelerating cell proliferation (Zhang et al., 2016). This evidence concerns the gene LFNG and pancreatic neoplasm.